# Protalix Biotherapeutics Inc. (PLX) — Revenue

## Annual Revenue (USD)

| Year | Revenue |
| --- | --- |
| 2025 | $53M |
| 2024 | $53M |
| 2023 | $65M |
| 2022 | $48M |
| 2021 | $38M |
| 2020 | $63M |
| 2019 | $55M |
| 2018 | $34M |
| 2017 | $21M |
| 2016 | $9M |
| 2015 | $4M |
| 2014 | $4M |
| 2013 | — |
| 2012 | $35M |
| 2011 | $8M |
| 2010 | $7M |
| 2009 | $388,000 |

## Quarterly Revenue (USD)

| Quarter | Revenue |
| --- | --- |
| 2026-03-31 | $34M |
| 2025-09-30 | $18M |
| 2025-06-30 | $16M |
| 2025-03-31 | $10M |
| 2024-09-30 | $18M |
| 2024-06-30 | $13M |
| 2024-03-31 | $4M |
| 2023-09-30 | $10M |
| 2023-06-30 | $35M |
| 2023-03-31 | $10M |
| 2022-09-30 | $14M |
| 2022-06-30 | $9M |
| 2022-03-31 | $16M |
| 2021-09-30 | $12M |
| 2021-06-30 | $6M |
| 2021-03-31 | $11M |
| 2020-09-30 | $11M |
| 2020-06-30 | $11M |
| 2020-03-31 | $22M |
| 2019-09-30 | $14M |
| 2019-06-30 | $12M |
| 2019-03-31 | $10M |
| 2018-09-30 | $663,000 |
| 2018-06-30 | $2M |

Source: [CompaniesByCap](https://companiesbycap.com/company/PLX/revenue)